Literature DB >> 18536915

Therapy options for treatment of hepatic malignancy.

Teresa Szyszko, Alison Brooks, Paul Tait, Domenico Rubello, Adil AL-Nahhas.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18536915     DOI： 10.1007/s00259-008-0798-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  23 in total

1.  Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.

Authors:  W Y Lau; T W Leung; S K Ho; M Chan; D Machin; J Lau; A T Chan; W Yeo; T S Mok; S C Yu; N W Leung; P J Johnson
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

Review 2.  Randomized clinical trials in advanced and metastatic colorectal carcinoma.

Authors:  Michael I Dangelica; Margo C Shoup; Aviram Nissan
Journal:  Surg Oncol Clin N Am       Date:  2002-01       Impact factor: 3.495

3.  Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres.

Authors:  Teresa Szyszko; Adil Al-Nahhas; Paul Tait; D Rubello; Ruben Canelo; Nagy Habib; Long Jiao; Harpreet Wasan; D Bansi; A Thillainayagam; K Nijran; G Stamp; E O'Rourke
Journal:  Nucl Med Commun       Date:  2007-01       Impact factor: 1.690

4.  Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.

Authors:  Teresa Szyszko; Adil Al-Nahhas; Ruben Canelo; Nagy Habib; Long Jiao; Harpreet Wasan; Margarita Pagou; Paul Tait
Journal:  Nucl Med Commun       Date:  2007-01       Impact factor: 1.690

5.  Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.

Authors:  Guy Van Hazel; Anthony Blackwell; James Anderson; David Price; Paul Moroz; Geoff Bower; Giuseppe Cardaci; Bruce Gray
Journal:  J Surg Oncol       Date:  2004-11-01       Impact factor: 3.454

Review 6.  Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.

Authors:  Ravi Murthy; Rodolfo Nunez; Janio Szklaruk; William Erwin; David C Madoff; Sanjay Gupta; Kamran Ahrar; Michael J Wallace; Alan Cohen; Douglas M Coldwell; Andrew S Kennedy; Marshall E Hicks
Journal:  Radiographics       Date:  2005-10       Impact factor: 5.333

7.  Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol.

Authors:  J-L Raoul; M Messner; E Boucher; J-F Bretagne; J-P Campion; K Boudjema
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

Review 8.  A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors.

Authors:  Sean Garrean; Justin Hering; W Scott Helton; N Joseph Espat
Journal:  Am J Surg       Date:  2007-07       Impact factor: 2.565

Review 9.  Chemoembolization of hepatocellular carcinoma.

Authors:  Douglas E Ramsey; Lily Y Kernagis; Michael C Soulen; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2002-09       Impact factor: 3.464

10.  Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.

Authors:  Patricia Bernal; Jean-Luc Raoul; Gaj Vidmar; Erdenechimeg Sereegotov; Felix X Sundram; Ajay Kumar; Jae Min Jeong; Pawana Pusuwan; Chaitanya Divgi; Pat Zanzonico; Janez Stare; John Buscombe; Chau Trinh Thi Minh; Maung Maung Saw; Shaoliang Chen; Ruben Ogbac; Ajit K Padhy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-09       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.